Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.

International immunopharmacology - 1 Aug 2011

Wu Tse-Yu, Fridley Brooke L, Jenkins Gregory D, Batzler Anthony, Wang Liewei, Weinshilboum Richard M

Abstract excerpt

Mycophenolic acid (MPA) is commonly used to treat patients with solid organ transplants during maintenance immunosuppressive therapy. Response to MPA varies widely, both for efficacy and drug-induced toxicity. A portion of this variation can be explained by pharmacokinetic and pharmacodynamic fac...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Autoantigens
Share to Cytochrome b Group

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to HeLa Cells

Share to Mycophenolic Acid

Share to Oxidoreductases

Share to Ribonucleoside Diphosphate Reductase

Source

Open in PubMed Open full text

Identifiers

PMID: 21396482
DOI: 10.1016/j.intimp.2011.02.027
PMCID: PMC3138818

Genes

CYBRD1
NASP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21396482-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.PMID 21396482Read ↗

Influence of Genetic Polymorphisms on Mycophenolic Acid Pharmacokinetics and Patient Outcomes in Renal Transplantation.Semantic proximity Read ↗

An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.Semantic proximity Read ↗

Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping reviewSemantic proximity Read ↗

The important role of MDM2, RPL5, and TP53 in mycophenolic acid-induced cleft lip and palate.Semantic proximity Read ↗

The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis.Semantic proximity Read ↗

Pharmacogenetic influences on mycophenolate therapy.Semantic proximity Read ↗

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.Semantic proximity Read ↗

The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants.Semantic proximity Read ↗

Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.Semantic proximity Read ↗

Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.Semantic proximity Read ↗

Regression and Genomic Analyses on the Association Between Dose-Normalized Mycophenolic Acid Exposure and Absolute Neutrophil Count in Steroid-Free, De Novo Kidney Transplant Recipients.Semantic proximity Read ↗

Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.